MedAdvisor Limited announced a new 5-year agreement with pharmacy wholesaler, Australian Pharmaceutical Industries Limited. As part of a total brand digital program, the MedAdvisor functionality will enable the Priceline Pharmacy network to better support its customers manage their total health and wellbeing MedAdvisor will develop a branded app for Priceline Pharmacy that will be developed as part of a total brand digital program to enable the API pharmacy network to better support its customers through innovative technology. The new Priceline Pharmacy application will be linked with the Priceline Sister Club, offering their 8 million members an easier way to manage their medications. The MedAdvisor solution provides improved workflows for COVID-19 vaccinations, including facilitating booking, storing patient records and retrieving vaccination history for the Australian Immunisation Record (AIR), claiming and uploading to the AIR. Following the recent announcement of COVID-19 vaccinations being available in selected pharmacies, it is expected that demand for this capability will continue to grow. MedAdvisor will receive a monthly recurring licence fee from each participating API pharmacy and this is expected to generate approximately $2.5 million over 5 years. In addition, MedAdvisor will generate additional revenue from transaction, messaging and health program fees. API will be converting to the MedAdvisor service from September 2021, with first revenues expected in second quarter fiscal 2022. This partnership is expected to increase MedAdvisor's patient reach and aligns with the strategic priority of growing domestic revenues and increasing revenue from growing market share.